ReviewInternational journal of molecular sciences2022

Recent Progress and Challenges in the Development of Antisense Therapies for Myotonic Dystrophy Type 1.

Thiéry De Serres-Bérard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.